ProCE Banner Activity

Reshaping Cancer Care: Current Best Practices for Precision Medicine in Patients With Advanced Solid Tumors

Slideset

Download these slides for an overview of the role of precision medicine in the treatment of advanced solid tumors, best practices, and currently approved tissue-agnostic therapies.

Released: September 13, 2024

Expiration: September 12, 2025

Share

Faculty

Alanna Church

Alanna Church, MD

Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP)
Program Director, Harvard Molecular Genetic Pathology Fellowship
Assistant Professor, Harvard Medical School
Boston Children’s Hospital
Boston, Massachusetts

Alexander E. Drilon

Alexander E. Drilon, MD

Chief, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC, in partnership with Q Synthesis and the Association for Molecular Pathology.

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

AMP

ProCE Banner

Q Synthesis LLC

ProCE Banner